First Squawk(@FirstSquawk):MERCK ENTERS INTO EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH SCIBRUNCH THERAPEUTICS FOR SPR2015, AN INVESTIGATIONAL ORAL KRAS G12D (ON) INHIBITOR (DESIGNED TO BLOCK THE KRAS G12D GENE MUTATION THAT CAUSES TUMOURS TO GROW IN CANCERS LIKE PANCREATIC AND COLORECTAL CANCER)

First Squawk

@FirstSquawk

Firstsquawk Is a Global Financial (News) Squawk Service Specialising In Financial Markets, Macro, Geopolitics,politics

参加 July 2015

251 フォロー中 568.6K ファン

First Squawk@FirstSquawk

9hours ago

MERCK ENTERS INTO EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH SCIBRUNCH THERAPEUTICS FOR SPR2015, AN INVESTIGATIONAL ORAL KRAS G12D (ON) INHIBITOR (DESIGNED TO BLOCK THE KRAS G12D GENE MUTATION THAT CAUSES TUMOURS TO GROW IN CANCERS LIKE PANCREATIC AND COLORECTAL CANCER)